Analysis of The Cancer Genome Atlas (TCGA) datasets indicated a progressive increase in ERK3 expression levels with the advancing stage of pancreatic cancer (Figure 2D), and that pancreatic cancer patients with poor prognosis have high ERK3 expression (Figure 2E). This evidence concerns the gene MAPK6 and pancreatic neoplasm.